The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Marker Therapeutics, Inc.

Related Interviews

Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
March 02, 2026
Brozak, Steve

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Niagen Bioscience Inc. (NASDAQ:NAGE)
Interview with the CEO: Vaxart Inc. (OTCMKTS:VXRT)
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
$TDW, Tidewater’s Supply Moat Widens as High Construction Costs Make New Vessels Financially Unviable for Competitors
Booking Holdings $BKNG: Scale Moat and Strategic OpenAI Pivot Neutralize AI Disruption Fears
Supply Constraints Translate Into Pricing Power for Eagle Materials
ANALYST INTERVIEWS
Argenx Builds Momentum on Strong Execution and Expanding Indications
Omeros Tackles Lethal Transplant Risks with First-in-Class Therapy
Uptick in M&A Among Tailwinds Boosting Biotech Sector
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy